United Spirits Ltd. share price target

In Q4FY26, the company's consolidated revenue rose 4.7% YoY to Rs. 6,855cr. Net sales, excluding excise duty, increased 3.7% YoY to Rs. 3,054cr, driven by resilient premium portfolio growth, a favourable price/mix and broad-based strength outside...

United Spirits’ (UNSP) revenue grew 7% YoY (in line) in 3QFY26. Total volume declined 3% YoY (vs. est. +2% | +8% in 2QFY26). We expected a volume decline given the policy change impact in Maharashtra and heavy
base due to AP.

United Spirits continues to demonstrate resilient growth, led by sustained momentum in the P&A portfolio, an improving product mix and steady volume recovery across key markets. Management remains focussed on strengthening the premium portfolio and sharper brand execution, which should continue to support margin traction. With commodity inflation largely stabilised and productivity programme delivering measurable benefits, the margin framework is expected to be stronger into H2FY26. The company expects healthy demand, driven by festive...

United Spirits (UNSP) delivered a strong performance in 2QFY26, with revenue rising 12% YoY (beat) and total volumes up 8% (vs. est. 6%).

United Spirits (UNSP) reported revenue growth of 15% YoY (est. 13%) in 3QFY25, along with total volume growth of 10% (est. 8%). The Prestige & Above (P&A) segment clocked volume and value growth of 11% and 16%.

Quarterly Update Q1FY25

UNSP reported revenue growth of 8% YoY (in line) in 1QFY25. Prestige & Above (P&A) segment clocked revenue growth of 10% YoY and volume growth of 5% YoY.

Quarterly Update Q4FY24

United Spirits (UNSP) registered a 6.9% YoY revenue growth (est. 3.9%). The
Prestige & Above (P&A) segment grew 6.5% YoY, with volume growth of
3.7% YoY (10% four-year CAGR). The popular segment posted 3.3%/4.0%
YoY value/volume growth

Quarterly Update Q3FY24

Quarterly Update Q2FY24

Double-digit revenue growth trajectory continues as Prestige and Above (P&A) continued to outperform primarily led by higher realisations (driven by premiumisation) as volumes growth trajectory decelerates to 4% YoY (vs ~10% over last two quarters). This is likely due to shift in festive season and BIO normalisation benefits getting over.

Quarterly Update Q1FY24

Prestige and Above (P&A) continued to outperform led by mix improvement, portfolio reshape initiatives through innovations and renovations. Balanced volume (10% YoY) and price/mix growth (11% YoY) in P&A is positive vs largely mix-driven growth in previous few quarters.

Quarterly Update Q4FY23

Continued outperformance in Prestige & Above (P&A) in Q4FY23 driven by portfolio reshape initiatives through innovations and renovations is pleasing. Further, balanced volume (~10% YoY) and price / mix growth (~12% YoY) in Q4FY23 vs largely mix driven growth in previous few quarters is also good though it had benefits of BIO normalisation.

Initiating Coverage Report